- Home
- CELC vs MMD Comparison
CELC vs MMD Comparison
Compare CELC & MMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- MMD
- Stock Information
- Founded
- CELC 2011
- MMD 2012
- Country
- CELC United States
- MMD United States
- Employees
- CELC N/A
- MMD N/A
- Industry
- CELC Medical Specialities
- MMD Investment Managers
- Sector
- CELC Health Care
- MMD Finance
- Exchange
- CELC Nasdaq
- MMD Nasdaq
- Market Cap
- CELC 327.3M
- MMD 268.0M
- IPO Year
- CELC 2017
- MMD N/A
- Fundamental
- Price
- CELC $11.62
- MMD $14.42
- Analyst Decision
- CELC Strong Buy
- MMD
- Analyst Count
- CELC 5
- MMD 0
- Target Price
- CELC $30.80
- MMD N/A
- AVG Volume (30 Days)
- CELC 148.5K
- MMD 74.7K
- Earning Date
- CELC 05-14-2025
- MMD 01-01-0001
- Dividend Yield
- CELC N/A
- MMD 4.88%
- EPS Growth
- CELC N/A
- MMD N/A
- EPS
- CELC N/A
- MMD N/A
- Revenue
- CELC N/A
- MMD N/A
- Revenue This Year
- CELC N/A
- MMD N/A
- Revenue Next Year
- CELC N/A
- MMD N/A
- P/E Ratio
- CELC N/A
- MMD N/A
- Revenue Growth
- CELC N/A
- MMD N/A
- 52 Week Low
- CELC $7.58
- MMD $14.30
- 52 Week High
- CELC $19.77
- MMD $17.67
- Technical
- Relative Strength Index (RSI)
- CELC 64.24
- MMD 40.66
- Support Level
- CELC $10.50
- MMD $14.41
- Resistance Level
- CELC $10.88
- MMD $14.60
- Average True Range (ATR)
- CELC 0.62
- MMD 0.15
- MACD
- CELC 0.05
- MMD -0.02
- Stochastic Oscillator
- CELC 90.17
- MMD 10.48
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
MainStay MacKay DefinedTerm Municipal Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.